Search the Newsreel

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

Clean Harbors to acquire EnviroServe for $470 million in cash

Clean Harbors, Inc. (NYSE:CLH) has announced an agreement to acquire EnviroServe, a national environmental and waste management services provider, for $470 million in cash. EnviroServe, with 40 locations and over 700 employees, is expected to generate $250 million in annual revenues and $27 million …

Borr Drilling Limited - Q2 2026 Presentation

This document is the Q2 2026 Presentation for Borr Drilling Limited. It contains the company's financial results and operational updates for the second quarter of 2026.

Borr Drilling sinks as Q2 swings to loss on Iran war impacts (BORR:NYSE)

CAPLIPOINT: 20% revenue growth, strong margins, and major capacity expansion drive future outlook

Clean Harbors To Buy EnviroServe For $470 Mln In Cash

(RTTNews) - Wednesday, Clean Harbors, Inc. (CLH) announced its plan to acquire EnviroServe, a national provider of environmental and waste management services, from an affiliate of One Rock Capital Partners, LLC for $470 million in cash. The transaction is expected to strengthen the company's …

One Rock Capital Partners Announces Sale of EnviroServe to Clean Harbors

NEW YORK, August 12, 2026--(BUSINESS WIRE)--One Rock Capital Partners, LLC (together with its affiliates, "One Rock"), a value-oriented, operationally focused private equity firm, today announced that it has entered into a definitive agreement to sell EnviroServe Inc. and its related affiliates (collectively, "EnviroServe" or …

Borr Drilling Limited Q2 2026 Earnings Call Summary

Borr Drilling (NYSE: BORR) posts $270M H1 2026 loss amid refinancing and rig expansion

Mesa Laboratories (MLAB) Stock Jumps As Margin Gains Meet Backlog Doubts

Mesa Laboratories' stock jumped 9.5% after its Q1 2027 earnings, with investors focusing on improved profitability despite modest revenue growth. Gross margins increased, and cash generation was solid, but net income and EPS declined year-on-year. The company faces risks from backlog issues and customer …

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Reborn Coffee (REBN) signs $20M annual agricultural supply pact with Mighty Oak

Reborn Coffee, Inc. (REBN) has signed a two-year Agricultural Import and Supply Agreement with The Mighty Oak, Inc., guaranteeing an annual minimum supply and import volume of $20 million. This agreement outlines Reborn Coffee's role in importing and supplying agricultural products to Mighty Oak …

Reborn Coffee Strikes Two-Year Supply Pact With Mighty Oak, $20 Million Annual Minimum

Reborn Coffee (REBN) has signed a two-year Agricultural Import and Supply Agreement with Mighty Oak, featuring a minimum annual purchase commitment of $20 million. This deal aims to expand Reborn Coffee's U.S. distribution and secure committed purchase volumes for agricultural products destined for major …

Labcorp (LH) Stock Looks About Right On Raised Full Year Guidance

Labcorp (LH) stock appears to be fairly valued according to Discounted Cash Flow and P/E ratio analyses, following a 54.1% increase over the last three years and a recent raise in full-year guidance. The intrinsic value estimate is close to the current share price, …

Borana Weaves Q1 Results: Unaudited Financials for June 30 Quarter Approved

Indo Borax & Chemicals opens postal ballot e-voting for shareholders

Caplin Point Laboratories fixes Sept 18 record date for 35th AGM

Charles River Laboratories International, Inc. $CRL Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in Charles River Laboratories International (NYSE: CRL) by 98.4% in the first quarter, selling over 151,000 shares. Despite this, analyst sentiment remains largely positive, with a consensus "Moderate Buy" rating and a $255.65 average price target. The …

Idexx Laboratories (IDXX) Receives a Buy from Barclays

Asymchem Labs Sets Board Meeting to Approve 2026 Interim Results

Two Harbors Investments (NYSE:TWO) Hits New 12-Month Low - What's Next?

CAPLIPOINT: Q1 FY27 revenue grew 20.7% YoY to ₹644 Crores, with PAT up 18.8% to ₹179 Crores

CAPLIPOINT: Q1 FY27 delivered double-digit revenue and profit growth, with strong expansion in key markets

Butensky & Cohen Financial Security Inc. Purchases 9,277 Shares of Abbott Laboratories $ABT

Butensky & Cohen Financial Security Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 26.9% in the second quarter, acquiring an additional 9,277 shares to own a total of 43,809 shares valued at $3.98 million. This move comes as Abbott Laboratories reported strong quarterly …

Unichem Laboratories shareholders approve Bhattacharyya reappointment at AGM

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Kuzey Boru’nun 6 aylık kârı 260 milyon TL’ye geriledi

Tamboran Resources Corp (TBN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Projeções de Resultados: Borgwarner Inc (BWA) — LPA e Crescimento de Receita

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Labcorp Holdings Inc. (NYSE:LH) has received a consensus "Moderate Buy" rating from twelve brokerages, with an average 12-month price target of $330.00. The company recently surpassed quarterly earnings expectations with $4.99 EPS and $3.73 billion in revenue, and declared a quarterly dividend of $0.72 …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

Dr. Reddy's Laboratories slides Wednesday, underperforms competitors

Dr. Reddy's Laboratories Ltd. shares fell 0.50% on Wednesday to 1,198.95 Indian rupees, underperforming the broader market as the BSE SENSEX Index dropped 0.24%. The company's stock closed 15.23% below its 52-week high achieved on June 29th.

Borr Drilling: Q2 Earnings Snapshot

The article "Borr Drilling: Q2 Earnings Snapshot" is a placeholder for an earnings report. The current content is empty except for a privacy protection message, indicating that the actual financial details for Borr Drilling's Q2 earnings are not yet available or were not included …

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating

Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …

Borr Drilling Reports Quarterly Loss

Borr Drilling reported a significant net loss of $241.4 million in Q2 2026, primarily due to a large debt extinguishment charge, despite generating $232.3 million in operating revenues. The company's adjusted EBITDA decreased by 51% to $43.8 million, attributed to delays with the Odin …